Richard Tilman Hauch
Publications
- 2023
Correction: Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT
Hauch, R., Hinrichs, M., Ruhwald, R., Schrum, J., Rutkowski, S., Woessmann, W. & Winkler, B., 05.2023, In: KLIN PADIATR. 235, 3, p. e1-e2Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT: A Monocentric, Retrospective Study
Hauch, R., Hinrichs, M., Ruhwald, R., Schrum, J., Rutkowski, S., Woessmann, W. & Winkler, B., 05.2023, In: KLIN PADIATR. 235, 3, p. 159-166 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Elevated RIPK3 correlates with disease burden in myelofibrosis
Dill, V., Wagner, C. V., Keller, E. C., Fernandez-Hernandez, F. J., Shoumariyeh, K., Odinius, T. O., Buschhorn, L., Hauch, R. T., Suren, C., Hecker, J. S., Herhaus, P., Sandherr, M., Schmidt, B., Slotta-Huspenina, J., Bassermann, F., Höckendorf, U., Jilg, S., Branca, C., Vosberg, S. & Jost, P. J., 11.04.2023, In: BLOOD ADV. 7, 7, p. 1219-1224 6 p.Research output: SCORING: Contribution to journal › Letter › Research
- 2022
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies
Odinius, T. O., Buschhorn, L., Wagner, C., Hauch, R. T., Dill, V., Dechant, M., Buck, M. C., Shoumariyeh, K., Moog, P., Schwaab, J., Reiter, A., Brockow, K., Götze, K., Bassermann, F., Höckendorf, U., Branca, C., Jost, P. J. & Jilg, S., 02.2022, In: J CANCER RES CLIN. 148, 2, p. 331-340 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
Dill, V., Kauschinger, J., Hauch, R. T., Buschhorn, L., Odinius, T. O., Müller-Thomas, C., Mishra, R., Kyncl, M. C., Schmidt, B., Prodinger, P. M., Hempel, D., Bellos, F., Höllein, A., Kern, W., Haferlach, T., Slotta-Huspenina, J., Bassermann, F., Peschel, C., Götze, K. S., Waizenegger, I. C., Höckendorf, U., Jost, P. J. & Jilg, S., 22.11.2019, In: EUR J HAEMATOL. 104, 2, p. 125-137 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Jilg, S., Hauch, R. T., Kauschinger, J., Buschhorn, L., Odinius, T. O., Dill, V., Müller-Thomas, C., Herold, T., Prodinger, P. M., Schmidt, B., Hempel, D., Bassermann, F., Peschel, C., Götze, K. S., Höckendorf, U., Haferlach, T. & Jost, P. J., 16.04.2019, In: EXP HEMATOL ONCOL. 8, p. 9Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Reidel, V., Kauschinger, J., Hauch, R. T., Müller-Thomas, C., Nadarajah, N., Burgkart, R., Schmidt, B., Hempel, D., Jacob, A., Slotta-Huspenina, J., Höckendorf, U., Peschel, C., Kern, W., Haferlach, T., Götze, K. S., Jilg, S. & Jost, P. J., 03.04.2019, In: ONCOTARGET. 9, 25, p. 17270-17281 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review